Oxbow Advisors LLC Has $3.13 Million Position in Colgate-Palmolive Company $CL

Oxbow Advisors LLC reduced its position in shares of Colgate-Palmolive Company (NYSE:CL) by 46.4% in the 4th quarter, HoldingsChannel reports. The firm owned 39,659 shares of the company’s stock after selling 34,327 shares during the period. Oxbow Advisors LLC’s holdings in Colgate-Palmolive were worth $3,134,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Diamond Hill Capital Management Inc. lifted its position in shares of Colgate-Palmolive by 46.7% during the third quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock worth $645,719,000 after purchasing an additional 2,572,796 shares in the last quarter. Amundi raised its position in Colgate-Palmolive by 41.6% in the 3rd quarter. Amundi now owns 6,294,445 shares of the company’s stock worth $487,505,000 after purchasing an additional 1,850,412 shares during the last quarter. Two Sigma Investments LP raised its position in Colgate-Palmolive by 360.9% in the 3rd quarter. Two Sigma Investments LP now owns 2,126,249 shares of the company’s stock worth $169,972,000 after purchasing an additional 1,664,949 shares during the last quarter. SG Americas Securities LLC lifted its holdings in Colgate-Palmolive by 3,896.0% during the 4th quarter. SG Americas Securities LLC now owns 1,189,005 shares of the company’s stock worth $93,955,000 after buying an additional 1,159,250 shares in the last quarter. Finally, Vanguard Group Inc. boosted its position in Colgate-Palmolive by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 83,947,987 shares of the company’s stock valued at $6,633,570,000 after buying an additional 1,026,985 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $87.53 on Friday. The stock has a market cap of $70.22 billion, a PE ratio of 34.06, a price-to-earnings-growth ratio of 4.54 and a beta of 0.31. The stock has a 50-day moving average of $87.38 and a 200-day moving average of $84.34. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.29. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. During the same quarter last year, the firm earned $0.91 EPS. Colgate-Palmolive’s quarterly revenue was up 8.4% compared to the same quarter last year. As a group, sell-side analysts expect that Colgate-Palmolive Company will post 3.83 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be issued a dividend of $0.53 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.4%. Colgate-Palmolive’s dividend payout ratio is currently 82.49%.

Insider Activity

In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 15,000 shares of Colgate-Palmolive stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $97.81, for a total value of $1,467,150.00. Following the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at $1,018,691.15. This trade represents a 59.02% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the transaction, the insider directly owned 17,645 shares of the company’s stock, valued at $1,663,041.25. This represents a 54.33% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 70,989 shares of company stock worth $6,756,713 in the last three months. Company insiders own 0.43% of the company’s stock.

Analyst Upgrades and Downgrades

CL has been the topic of several recent research reports. Piper Sandler decreased their price target on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, April 8th. JPMorgan Chase & Co. raised their target price on shares of Colgate-Palmolive from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, May 4th. Morgan Stanley reiterated an “overweight” rating on shares of Colgate-Palmolive in a research report on Monday, May 4th. TD Cowen reissued a “hold” rating and set a $85.00 price target on shares of Colgate-Palmolive in a research note on Tuesday, March 31st. Finally, Citigroup raised their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, February 2nd. Twelve investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.